Zosano Pharma Corporation (NASDAQ:ZSAN) Stock Corrects 11% in a Month: A Good Opportunity?
Zosano Pharma Corporation (NASDAQ:ZSAN) is down 11% in a month. The company reported its Q2 financial results and business highlights for the period ending June 30, 2021. CEO Steven Lo said they are delighted to have commenced the healthy volunteer’s pharmacokinetic study requested by the US FDA for NDA resubmission for M207. Lo said that the study evaluated safety and pharmacokinetics in 38 healthy volunteers. The company is working to…